日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tuberculosis outbreak in a German daycare center

德国一家日托中心爆发结核病疫情

Feiterna-Sperling, Cornelia; von Hake, Julia; Lala, Birgit; Völler, Mirjam; Zaidan-Braun, Lujin; Martin, Luise; Günther, Annette; von Schöning, Dinah; Krüger, Renate

Immunopathogenic and clinical implications of advanced tissue analysis in non-tuberculous mycobacterial infections in children

儿童非结核分枝杆菌感染中高级组织分析的免疫病理学和临床意义

Seidl, Maximilian; Haghighi, Elham Bavafaye; Lösslein, Anne Kathrin; Hufnagel, Markus; Lohrmann, Florens; Schneider, Christian; Kohlfürst, Daniela S; Zenz, Werner; Gorkiewicz, Gregor; Feiterna-Sperling, Cornelia; Krüger, Renate; Bronsert, Peter; Neppl, Christina; Sommer, Kim Zoe; Stehl, Verena; Boerries, Melanie; Kuntz, Martin; Henneke, Philipp

Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland

在奥地利、德国和瑞士治疗耐多药结核病、前广泛耐药结核病、广泛耐药结核病和利福平耐药结核病,或对至少利福平不耐受的情况

Otto-Knapp, Ralf; Bauer, Torsten; Brinkmann, Folke; Feiterna-Sperling, Cornelia; Friesen, Inna; Geerdes-Fenge, Hilte; Hartmann, Pia; Häcker, Brit; Heyckendorf, Jan; Kuhns, Martin; Lange, Christoph; Maurer, Florian P; Nienhaus, Albert; Priwitzer, Martin; Richter, Elvira; Salzer, Helmut J F; Schoch, Otto D; Schönfeld, Nicolas; Schaberg, Tom

[Tuberculosis-Update 2022]

[结核病最新进展 2022]

Kainz, Katharina; Brinkmann, Folke; Bogyi, Matthias; Feiterna-Sperling, Cornelia; Götzinger, Florian; Mädel, Clemens; Thee, Stephanie; Krüger, Renate

Pilot study to identify missed opportunities for prevention of childhood tuberculosis

旨在找出预防儿童结核病错失机会的试点研究

Feiterna-Sperling, Cornelia; Thoulass, Janine; Krüger, Renate; Haas, Walter; Hauer, Barbara

Correction to: Pilot study to identify missed opportunities for prevention of childhood tuberculosis

更正:旨在找出预防儿童结核病错失机会的试点研究

Feiterna-Sperling, Cornelia; Thoulass, Janine; Krüger, Renate; Haas, Walter; Hauer, Barbara

Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study

格卡瑞韦/哌仑他韦治疗慢性丙型肝炎患儿的药代动力学、安全性和疗效:DORA 研究第二部分

Jonas, Maureen M; Rhee, Susan; Kelly, Deirdre A; Del Valle-Segarra, Antonio; Feiterna-Sperling, Cornelia; Gilmour, Susan; Gonzalez-Peralta, Regino P; Hierro, Loreto; Leung, Daniel H; Ling, Simon C; Lobzin, Yuri; Lobritto, Steven; Mizuochi, Tatsuki; Narkewicz, Michael R; Sabharwal, Vishakha; Wen, Jessica; Kei Lon, Hoi; Marcinak, John; Topp, Andrew; Tripathi, Rakesh; Sokal, Etienne

Mediastinal mass in an tuberculosis-exposed 2-year old child with neurofibromatosis type 1 - TB or not TB?

一名曾接触过结核病的2岁神经纤维瘤病1型患儿出现纵隔肿块——是结核病还是非结核病?

Krüger, Renate; Potratz, Cornelia; Hernáiz-Driever, Pablo; Lala, Birgit; Feiterna-Sperling, Cornelia

Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection

索非布韦和利巴韦林治疗3至12岁以下感染丙型肝炎病毒2型或3型的儿童

Rosenthal, Philip; Schwarz, Kathleen B; Gonzalez-Peralta, Regino P; Lin, Chuan-Hao; Kelly, Deidre A; Nightingale, Scott; Balistreri, William F; Bansal, Sanjay; Jonas, Maureen M; Massetto, Benedetta; Brainard, Diana M; Hsueh, Chia-Hsiang; Shao, Jiang; Parhy, Bandita; Davison, Suzanne; Feiterna-Sperling, Cornelia; Gillis, Lynette A; Indolfi, Giuseppe; Sokal, Etienne M; Murray, Karen F; Wirth, Stefan

Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study

格卡瑞韦/哌仑他韦在慢性丙型肝炎病毒感染青少年中的药代动力学、安全性和有效性:DORA 研究的第一部分

Jonas, Maureen M; Squires, Robert H; Rhee, Susan M; Lin, Chih-Wei; Bessho, Kazuhiko; Feiterna-Sperling, Cornelia; Hierro, Loreto; Kelly, Deirdre; Ling, Simon C; Strokova, Tatiana; Del Valle-Segarra, Antonio; Lovell, Sandra; Liu, Wei; Ng, Teresa I; Porcalla, Ariel; Gonzalez, Yuri Sanchez; Burroughs, Margaret; Sokal, Etienne